Marksans Pharma

'Marksans Pharma' - 20 News Result(s)

  • Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
    Business | Edited by Abhishek Vasudev | Thursday August 26, 2021
    Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
    www.ndtv.com/business
  • Marksans Pharma Surges On FDA Nod For New Drug
    Business | Edited by Abhishek Vasudev | Monday September 26, 2016
    Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs 53.85 after the company announced that it has received US drug regulator's approval for a medicine used in treatment of sneezing, runny nose and other allergies.
    www.ndtv.com/business
  • Marksans Pharma Gets US Drug Regulator's Approval For Allergy Drug
    Business | Press Trust of India | Monday September 26, 2016
    In a BSE filing today, Marksans Pharma said, "USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg."
    www.ndtv.com/business
  • Marksans Pharma Gets US Regulator's Nod For Diabetes Drug
    Business | Press Trust of India | Monday May 2, 2016
    Marksans Pharma has received approval from the US Food and Drug Administration (FDA) for its Metformin Hydrochloride tablets, used for treatment of diabetes, in the American market.
    www.ndtv.com/business
  • UK's Drug Regulator Issues Restricted GMP Certificate to Marksans Pharma
    Business | Press Trust of India | Thursday March 17, 2016
    The company has received communication from UK's MHRA informing that they are issuing a 'Restricted GMP Certificate' allowing the company to continue manufacture and marketing of critical products for the UK markets, Marksans Pharma said in a BSE filing.
    www.ndtv.com/business
  • Marksans Pharma's Goa Plant Under UK Regulator Scanner
    Business | Press Trust of India | Wednesday January 13, 2016
    Marksans Pharma on Wednesday said UK health regulator has issued "certain observations" regarding the company's Goa facility, after inspecting it in November.
    www.ndtv.com/business
  • India Inc's Overseas Investment Dips 32% at $1.23 Billion in July
    Business | Press Trust of India | Friday August 21, 2015
    Among major investors, Manipal Health Systems Pvt Ltd invested $108.8 million in a joint venture in Singapore, Ballarpur Industries $75.08 million in a wholly-owned manufacturing facility in the Netherlands.
    www.ndtv.com/business
  • Marksans Pharma Surges 50% in Six Trading Sessions
    Business | NDTV | Tuesday July 7, 2015
    Marksans Pharma shares have been in demand Since June 30 after the company said that it had acquired US-based Time-Cap Laboratories for an undisclosed amount.
    www.ndtv.com/business
  • Marksans Pharma Surges 10% on Acquisition of US-Based Time-Cap
    Business | Press Trust of India | Tuesday June 30, 2015
    Marksans Pharma shares rose over 9 per cent to touch an intraday high of Rs 64.40 on Tuesday after the company said that it has acquired US-based Time-Cap Laboratories for an undisclosed amount..
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 82.30% to Rs 55.60 croreMarksans Pharma reported net profit of Rs 5.08 crore in the quarter ended March 2010 as against net loss of Rs 13.43 crore during the previous quarter ended March 2009. Sales rose 82.30% to Rs 55.60 crore in the quarter ended March 2010 as against Rs 30.50 crore during the previous quarter ended March 2009.For the...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    On 14 April 2010 The board of Marksans Pharma in its meeting on 14 April 2010 has converted 1 Foreign Currency Convertible Bonds of US$ 1000 into 1,333 equity shares of Re. 1 each and allotted to the concerned bond holder.
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales decline 40.95% to Rs 40.27 croreMarksans Pharma reported net loss of Rs 3.53 crore in the quarter ended September 2009 as against net profit of Rs 6.96 crore during the previous quarter ended September 2008. Sales declined 40.95% to Rs 40.27 crore in the quarter ended September 2009 as against Rs 68.20 crore during the previous quarter ended ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    With effect from 25 September 2009Marksans Pharma has announced that Kim Tan, Director of the Company has retired as a director of the company with effect from 25 September 2009.The company made this announcement after the trading hours today, 30 September 2009.
    www.ndtv.com/business

'Marksans Pharma' - 20 News Result(s)

  • Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
    Business | Edited by Abhishek Vasudev | Thursday August 26, 2021
    Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
    www.ndtv.com/business
  • Marksans Pharma Surges On FDA Nod For New Drug
    Business | Edited by Abhishek Vasudev | Monday September 26, 2016
    Marksans Pharma shares surged as much as 12.5 per cent to hit intraday high of Rs 53.85 after the company announced that it has received US drug regulator's approval for a medicine used in treatment of sneezing, runny nose and other allergies.
    www.ndtv.com/business
  • Marksans Pharma Gets US Drug Regulator's Approval For Allergy Drug
    Business | Press Trust of India | Monday September 26, 2016
    In a BSE filing today, Marksans Pharma said, "USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg."
    www.ndtv.com/business
  • Marksans Pharma Gets US Regulator's Nod For Diabetes Drug
    Business | Press Trust of India | Monday May 2, 2016
    Marksans Pharma has received approval from the US Food and Drug Administration (FDA) for its Metformin Hydrochloride tablets, used for treatment of diabetes, in the American market.
    www.ndtv.com/business
  • UK's Drug Regulator Issues Restricted GMP Certificate to Marksans Pharma
    Business | Press Trust of India | Thursday March 17, 2016
    The company has received communication from UK's MHRA informing that they are issuing a 'Restricted GMP Certificate' allowing the company to continue manufacture and marketing of critical products for the UK markets, Marksans Pharma said in a BSE filing.
    www.ndtv.com/business
  • Marksans Pharma's Goa Plant Under UK Regulator Scanner
    Business | Press Trust of India | Wednesday January 13, 2016
    Marksans Pharma on Wednesday said UK health regulator has issued "certain observations" regarding the company's Goa facility, after inspecting it in November.
    www.ndtv.com/business
  • India Inc's Overseas Investment Dips 32% at $1.23 Billion in July
    Business | Press Trust of India | Friday August 21, 2015
    Among major investors, Manipal Health Systems Pvt Ltd invested $108.8 million in a joint venture in Singapore, Ballarpur Industries $75.08 million in a wholly-owned manufacturing facility in the Netherlands.
    www.ndtv.com/business
  • Marksans Pharma Surges 50% in Six Trading Sessions
    Business | NDTV | Tuesday July 7, 2015
    Marksans Pharma shares have been in demand Since June 30 after the company said that it had acquired US-based Time-Cap Laboratories for an undisclosed amount.
    www.ndtv.com/business
  • Marksans Pharma Surges 10% on Acquisition of US-Based Time-Cap
    Business | Press Trust of India | Tuesday June 30, 2015
    Marksans Pharma shares rose over 9 per cent to touch an intraday high of Rs 64.40 on Tuesday after the company said that it has acquired US-based Time-Cap Laboratories for an undisclosed amount..
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 82.30% to Rs 55.60 croreMarksans Pharma reported net profit of Rs 5.08 crore in the quarter ended March 2010 as against net loss of Rs 13.43 crore during the previous quarter ended March 2009. Sales rose 82.30% to Rs 55.60 crore in the quarter ended March 2010 as against Rs 30.50 crore during the previous quarter ended March 2009.For the...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    On 14 April 2010 The board of Marksans Pharma in its meeting on 14 April 2010 has converted 1 Foreign Currency Convertible Bonds of US$ 1000 into 1,333 equity shares of Re. 1 each and allotted to the concerned bond holder.
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales rise 24.07% to Rs 62.94 croreNet profit of Marksans Pharma rose 527.78% to Rs 1.13 crore in the quarter ended December 2009 as against Rs 0.18 crore during the previous quarter ended December 2008. Sales rose 24.07% to Rs 62.94 crore in the quarter ended December 2009 as against Rs 50.73 crore during the previous quarter ended December 2008. ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    Sales decline 40.95% to Rs 40.27 croreMarksans Pharma reported net loss of Rs 3.53 crore in the quarter ended September 2009 as against net profit of Rs 6.96 crore during the previous quarter ended September 2008. Sales declined 40.95% to Rs 40.27 crore in the quarter ended September 2009 as against Rs 68.20 crore during the previous quarter ended ...
    www.ndtv.com/business
  • Business | NDTV Correspondent | Friday November 25, 2011
    With effect from 25 September 2009Marksans Pharma has announced that Kim Tan, Director of the Company has retired as a director of the company with effect from 25 September 2009.The company made this announcement after the trading hours today, 30 September 2009.
    www.ndtv.com/business
Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com